Funding Opportunity RFA-DK-22-502 from the NIH Guide for Grants and Contracts. The purpose of this Limited Competition is to extend the Chronic Renal Insufficiency Cohort (CRIC) Study by continuing to support Clinical Centers that have previously enrolled and followed study participants. The CRIC Study is a multi-center, prospective, observational cohort study of men and women with chronic kidney disease (CKD). The primary objective of this FOA is to complete follow-up of the entire cohort. Under this FOA, the Clinical Centers will complete all data collection on enrolled participants and arrange to transfer these data and all collected biosamples to the Scientific and Data Coordinating Center (SDCC) for ultimate deposition into the NIDDK Central Biorepository.

Notice NOT-PM-22-004 from the NIH Guide for Grants and Contracts

Notice NOT-HD-22-034 from the NIH Guide for Grants and Contracts

Notice NOT-HD-22-033 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-CA-22-040 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for Biomarker Characterization Centers (BCCs), one of the three scientific units of the Early Detection Research Network (EDRN). The EDRN is a national infrastructure to discover, develop, and validate biomarkers and imaging methods for early cancer detection and risk assessment. BCCs will (1) discover, develop, characterize and test new biomarkers or refine existing biomarkers, (2) develop, refine and/or standardize biomarker assays, (3) provide resources and support for the validation of biomarkers developed by the EDRN, and (4) participate in collaborative projects with other laboratories and centers.The other two scientific units of the continuing EDRN program are the Clinical Validation Centers (CVCs), which will conduct clinical research on the validation of biomarkers and will serve as resource centers for the Network by participating in collaborative biomarker validation studies with EDRN BCCs; and the Data Management and Coordinating Center (DMCC), which will support statistical and computational analyses, informatics infrastructure, study design, coordination and management of EDRN-sponsored biomarker validation studies, and the coordination of Network-wide meetings and workshops.

Funding Opportunity RFA-CA-22-039 from the NIH Guide for Grants and Contracts. The objectives of the Early Detection Research Network (EDRN; edrn.cancer.gov) are to discover, develop and validate biomarkers and imaging methods to detect early stage cancers and to translate these into clinical tests. The EDRN provides an infrastructure that is essential for this process and has successfully completed more than10 multicenter validation studies.

Notice NOT-HL-22-026 from the NIH Guide for Grants and Contracts

Notice NOT-HL-22-025 from the NIH Guide for Grants and Contracts

Notice NOT-DE-22-003 from the NIH Guide for Grants and Contracts

Adapts bioinformatics tools, visualization packages, and annotation resources for research projects to independently and accurately perform research analysis,…
From Medical College of Wisconsin - Mon, 18 Jul 2022 09:10:23 GMT - View all Milwaukee, WI jobs

Notice NOT-CA-22-104 from the NIH Guide for Grants and Contracts

Basic knowledge and experience with molecular biology & genomic methodologies, including subcloning, DNA sequence analysis, and bioinformatics.
From INTERNATIONAL FLAVORS & FRAGRANCES - Fri, 15 Jul 2022 20:04:33 GMT - View all Madison, WI jobs

Competitive Salary: F. Hoffmann-La Roche AG: The PositionWe are seeking a talented and highly motivated Sub-Chapter lead for the Next Generation Sequencing (NGS) algorithms development team at th Santa Clara, California (US)

Competitive Salary: F. Hoffmann-La Roche AG: Roche Sequencing Solutions (RSS), a business within Roche Diagnostics, is focused on developing a disruptive Next-Generation Sequencing (NGS) platform United States (US)

Competitive Salary: F. Hoffmann-La Roche AG: The PositionThis position may be based out of Santa Clara, CA, USA, with remote work locations possible in The United States.Impact HealthcareRoche Se Santa Clara, California (US)

Competitive Salary: F. Hoffmann-La Roche AG: The PositionResponsibilitiesProvide technical and strategic leadership as a member of the lifecycle project teams to support decision making in assay Santa Clara, California (US)

Competitive Salary: F. Hoffmann-La Roche AG: Impact HealthcareRoche Sequencing is developing ground-breaking next-generation sequencing products that allow scientists/clinicians powerful new aven Santa Clara, California (US)

Competitive Salary: F. Hoffmann-La Roche AG: The PositionPlease note this position has the potential to support a remote work arrangement and may be based anywhere in the United StatesAt Roche, 9 United States (US)

Competitive Salary: F. Hoffmann-La Roche AG: The PositionThe OMNI Bioinformatics and Immunology departments at Genentech are seeking a highly motivated computational scientist to engage in therap San Francisco, California (US)

Competitive Salary: F. Hoffmann-La Roche AG: Impact HealthcareRoche Sequencing is not only changing science, but we are changing lives. Our software teams are laying the groundwork for the future Ottawa (Region), Ontario (CA)